192 related articles for article (PubMed ID: 19770576)
1. Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant Hep G2 cells through a mitochondria-dependent oxidative stress mechanism.
Chiou JF; Tai CJ; Wang YH; Liu TZ; Jen YM; Shiau CY
Cancer Biol Ther; 2009 Oct; 8(20):1904-13. PubMed ID: 19770576
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells.
Lange M; Abhari BA; Hinrichs TM; Fulda S; Liese J
Biochem Pharmacol; 2016 Oct; 118():9-17. PubMed ID: 27544320
[TBL] [Abstract][Full Text] [Related]
3. III-10, a newly synthesized flavonoid, induces cell apoptosis with the involvement of reactive oxygen species-mitochondria pathway in human hepatocellular carcinoma cells.
Dai Q; Yin Q; Zhao Y; Guo R; Li Z; Ma S; Lu N
Eur J Pharmacol; 2015 Oct; 764():353-362. PubMed ID: 26164795
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.
Fernando J; Sancho P; Fernández-Rodriguez CM; Lledó JL; Caja L; Campbell JS; Fausto N; Fabregat I
J Cell Physiol; 2012 Apr; 227(4):1319-25. PubMed ID: 21604268
[TBL] [Abstract][Full Text] [Related]
5. The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cells.
Huang R; Chen XQ; Huang Y; Chen N; Zeng H
Asian J Androl; 2010 Jul; 12(4):527-34. PubMed ID: 20473320
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial-dependent caspase activation pathway is involved in baicalein-induced apoptosis in human hepatoma J5 cells.
Kuo HM; Tsai HC; Lin YL; Yang JS; Huang AC; Yang MD; Hsu SC; Chung MC; Gibson Wood W; Chung JG
Int J Oncol; 2009 Oct; 35(4):717-24. PubMed ID: 19724907
[TBL] [Abstract][Full Text] [Related]
7. [Schedule-dependent effects of sorafenib in combination with paclitaxel on human hepatocellular carcinoma cell line BEL-7402].
Li N; Zhang Y; Wu T; Li M
Ai Zheng; 2009 Aug; 28(8):838-43. PubMed ID: 19664330
[TBL] [Abstract][Full Text] [Related]
8. The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cells.
Panka DJ; Wang W; Atkins MB; Mier JW
Cancer Res; 2006 Feb; 66(3):1611-9. PubMed ID: 16452220
[TBL] [Abstract][Full Text] [Related]
9. Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells.
Ou DL; Shen YC; Yu SL; Chen KF; Yeh PY; Fan HH; Feng WC; Wang CT; Lin LI; Hsu C; Cheng AL
Cancer Res; 2010 Nov; 70(22):9309-18. PubMed ID: 21062976
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo.
Coriat R; Nicco C; Chéreau C; Mir O; Alexandre J; Ropert S; Weill B; Chaussade S; Goldwasser F; Batteux F
Mol Cancer Ther; 2012 Oct; 11(10):2284-93. PubMed ID: 22902857
[TBL] [Abstract][Full Text] [Related]
11. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
Li Y; Xia J; Shao F; Zhou Y; Yu J; Wu H; Du J; Ren X
Biochem Biophys Res Commun; 2021 Jan; 534():877-884. PubMed ID: 33162029
[TBL] [Abstract][Full Text] [Related]
13. Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells.
Liese J; Hinrichs TM; Lange M; Fulda S
Anticancer Drugs; 2019 Mar; 30(3):209-217. PubMed ID: 30640794
[TBL] [Abstract][Full Text] [Related]
14. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells.
Louandre C; Marcq I; Bouhlal H; Lachaier E; Godin C; Saidak Z; François C; Chatelain D; Debuysscher V; Barbare JC; Chauffert B; Galmiche A
Cancer Lett; 2015 Jan; 356(2 Pt B):971-7. PubMed ID: 25444922
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid (EPA) induced apoptosis in HepG2 cells through ROS-Ca(2+)-JNK mitochondrial pathways.
Zhang Y; Han L; Qi W; Cheng D; Ma X; Hou L; Cao X; Wang C
Biochem Biophys Res Commun; 2015 Jan; 456(4):926-32. PubMed ID: 25529445
[TBL] [Abstract][Full Text] [Related]
16. The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress.
Rahmani M; Davis EM; Crabtree TR; Habibi JR; Nguyen TK; Dent P; Grant S
Mol Cell Biol; 2007 Aug; 27(15):5499-513. PubMed ID: 17548474
[TBL] [Abstract][Full Text] [Related]
17. JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells.
Heslop KA; Rovini A; Hunt EG; Fang D; Morris ME; Christie CF; Gooz MB; DeHart DN; Dang Y; Lemasters JJ; Maldonado EN
Biochem Pharmacol; 2020 Jan; 171():113728. PubMed ID: 31759978
[TBL] [Abstract][Full Text] [Related]
18. The mitochondria-independent cytotoxic effect of nelfinavir on leukemia cells can be enhanced by sorafenib-mediated mcl-1 downregulation and mitochondrial membrane destabilization.
Brüning A; Rahmeh M; Gingelmaier A; Friese K
Mol Cancer; 2010 Jan; 9():19. PubMed ID: 20105315
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial ROS burst as an early sign in sarsasapogenin-induced apoptosis in HepG2 cells.
Ni Y; Gong XG; Lu M; Chen HM; Wang Y
Cell Biol Int; 2008 Mar; 32(3):337-43. PubMed ID: 18262806
[TBL] [Abstract][Full Text] [Related]
20. Interplay of reactive oxygen species, intracellular Ca2+ and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxin.
Kim KY; Cho HJ; Yu SN; Kim SH; Yu HS; Park YM; Mirkheshti N; Kim SY; Song CS; Chatterjee B; Ahn SC
J Cell Biochem; 2013 May; 114(5):1124-34. PubMed ID: 23192945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
